Yüklüyor......
On the mark: genetically engineered immunotherapies for autoimmunity
Current therapies for autoimmunity cause significant morbidity and mortality. Adoptive immunotherapy using genetically engineered T cells has led to durable remissions of B cell leukemias and lymphomas, raising the question of whether the approach can be modified to target autoreactive B and T cells...
Kaydedildi:
| Yayımlandı: | Curr Opin Immunol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6901707/ https://ncbi.nlm.nih.gov/pubmed/31563849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2019.08.005 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|